Cannabis Council Shuts Down, Exposing Canada's Fractured Industry
The national trade group's closure leaves Canadian operators without unified federal advocacy as provincial fragmentation deepens.

Professional setting of a business meeting with individuals signing documents on a conference table.
Trade Group Collapse Signals Broader Industry Crisis
The Cannabis Council's closure is the first national-level trade-group failure in any G7 cannabis market. Founded in 2018 to represent licensed producers and retailers during federal legalization, the Council had shrunk from 42 member companies in 2022 to fewer than 15 by mid-2026, according to industry sources. Membership dues dried up as cash-strapped operators cut non-essential spending amid sustained price compression and oversupply.
The shutdown leaves a vacuum. No single organization now speaks for Canadian cannabis operators at the federal level. Provincial groups—Ontario Cannabis Store (OCS) vendor associations, British Columbia's licensed-producer coalitions—remain active but lack Ottawa lobbying bandwidth.
Federal Inaction and Provincial Silos Drive Fragmentation
Canada's cannabis framework has devolved into 13 separate regulatory regimes with no coordination mechanism. Health Canada hasn't revised the Cannabis Act since 2019 despite industry-wide calls for excise-tax reform, interprovincial trade liberalization, and edibles-potency increases. Provincial governments control retail licensing, taxation, and distribution, creating a patchwork that prevents scale economies.
Ontario's per-gram excise tax remains fixed at $1.00 despite wholesale prices falling to $2.50/g. Quebec bans most edibles formats. Alberta allows private retail; British Columbia operates a government monopoly. The Council had lobbied for federal preemption of provincial retail restrictions. That effort is now dead.
Operator Economics Remain Unsustainable
Gross margins for Canadian LPs averaged 18% in Q1 2026, down from 42% in 2020. Per-gram wholesale prices have fallen 63% since legalization while excise taxes remain flat, creating a structural margin squeeze. Tilray Brands (TLRY), Canopy Growth (CGC), and Aurora Cannabis (ACB) have each posted operating losses in four of the past five quarters.
Retail oversaturation compounds the problem. Ontario licensed 1,847 stores by June 2026—one per 8,200 residents—while per-store revenue fell to $1.2 million annually. The Council had pushed for retail-density caps. Provincial regulators ignored the recommendation.
Illicit Market Share Holds at 40%
Statistics Canada estimates the illicit market captured 40% of total cannabis sales in 2025, unchanged from 2023. Legal operators can't compete on price with untaxed sellers offering flower at $4/g versus $9/g in legal stores. The Council had advocated for enforcement funding increases and tax harmonization. Neither materialized.
Federal enforcement budgets for illicit cannabis have been flat since 2021. Provincial police forces report limited capacity to pursue unlicensed dispensaries, particularly in Ontario and British Columbia, where storefront proliferation outpaces inspection resources.
No Successor Organization in Sight
Industry sources report no active discussions to form a replacement national trade group. Remaining large operators—Tilray, Canopy, Organigram (OGI)—maintain individual government-affairs teams but lack collective bargaining leverage. Mid-tier producers, many operating under creditor protection, have cut lobbying budgets entirely.
The Council's dissolution follows a pattern: the Canadian Cannabis Retailers Association downsized 60% in 2025, and the Cannabis Growers of Canada merged into a broader agriculture lobby in 2024. For context on the broader regulatory challenges facing Canadian operators, see the CannIntel topic hub on Canada's cannabis industry.
What This Means for Operators and Policy
The Council's failure removes the last organized pressure point for federal cannabis reform. Health Canada's next Cannabis Act review isn't scheduled until 2028. Without a unified industry voice, provincial regulatory divergence will likely accelerate, further fragmenting the market.
Investors should note: Canadian LP valuations already reflect policy-failure risk—TLRY and CGC trade at 0.4x and 0.6x sales, respectively, versus 1.8x for U.S. MSOs. The absence of federal advocacy increases the probability of continued margin compression and market-share losses to illicit sellers. Next catalyst? Ontario's fall budget, which could address excise-tax indexing. No signals yet that it will.
Sources
The cannabis newsletter you forward to your team.
Federal policy, market data, grower alerts, and the one story that matters today. Sent every weekday at 7am. Free.
No spam. Unsubscribe with one click. 21+ only.
Related from Business

Michigan Cannabis Market Matures Into Consumer Products Play
Wholesale prices and margin compression signal the end of cultivation-led growth in the state's $3.2 billion market.

Releaf Becomes First B Corp Certified Medical Cannabis Company
UK-based Releaf earns B Corp status, setting a corporate governance benchmark for the global cannabis sector.

Curaleaf Secures First Approval for Standardized Cannabis Product
The MSO's regulatory clearance marks a shift toward pharmaceutical-grade cannabis in U.S. markets.
More from the newsroom

New York Launches Statewide Youth Cannabis Education Campaign
State officials roll out public health initiative targeting families and adolescents as legal market expands.

Morris County Raids Multiple Intoxicating Hemp Retailers
Law enforcement seized products from smoke shops and convenience stores selling hemp-derived THC items under New Jersey's enforcement sweep.

Ohio Can't Enforce New Hemp Law Against Some Companies Due to Injunction
A federal court order blocks Ohio from enforcing its hemp-derived cannabinoid restrictions against certain retailers, leaving enforcement fragmented.